Paper29902258
CRISPR-Cas antimicrobials: Challenges and future prospects.
Pursey E and 4 others. PLoS Pathog, 2018. Cited by 99 papers, by iCite.
Cite this record
ConductScience Library. CRISPR-Cas antimicrobials: Challenges and future prospects. Papers, record 29902258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29902258
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Infective Agents | Major topic |
| Bacteria | Major topic |
| CRISPR-Cas Systems | Major topic |
| Gene Editing | Major topic |
| Gene Expression Regulation, Bacterial | Major topic |
| Microbial Viability | Major topic |
| Genetic Engineering | |
| Transformation, Bacterial |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| BB/R010781/1 | Biotechnology and Biological Sciences Research Council | United Kingdom | PubMed | |
| MR/N007174/1 | Medical Research Council | United Kingdom | PubMed | |
| 109776/Z/15/Z | Wellcome Trust | United Kingdom | PubMed | |
| Wellcome Trust | United Kingdom | PubMed | ||
| BB/N017412/1 | Biotechnology and Biological Sciences Research Council | United Kingdom | PubMed |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25282355 | Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. | Nat Biotechnol | 2014 | https://conductscience.org/library/papers/25282355 | PubMed |
| 2 | 26190075 | Parallel compensatory evolution stabilizes plasmids across the parasitism-mutualism continuum. | Curr Biol | 2015 | https://conductscience.org/library/papers/26190075 | PubMed |
| 3 | 17059480 | Frequent conjugative transfer accelerates adaptation of a broad-host-range plasmid to an unfavorable Pseudomonas putida host. | FEMS Microbiol Ecol | 2007 | https://conductscience.org/library/papers/17059480 | PubMed |
| 4 | 24692635 | Metatranscriptomics of the human oral microbiome during health and disease. | mBio | 2014 | https://conductscience.org/library/papers/24692635 | PubMed |
| 5 | 28749735 | The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs. | Annu Rev Virol | 2017 | https://conductscience.org/library/papers/28749735 | PubMed |
| 6 | 26411297 | An updated evolutionary classification of CRISPR-Cas systems. | Nat Rev Microbiol | 2015 | https://conductscience.org/library/papers/26411297 | PubMed |
| 7 | 27250768 | Genetically Engineered Phages: a Review of Advances over the Last Decade. | Microbiol Mol Biol Rev | 2016 | https://conductscience.org/library/papers/27250768 | PubMed |
| 8 | 25240928 | Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. | Nat Biotechnol | 2014 | https://conductscience.org/library/papers/25240928 | PubMed |
| 9 | 27941126 | Evolution of Resistance Against CRISPR/Cas9 Gene Drive. | Genetics | 2017 | https://conductscience.org/library/papers/27941126 | PubMed |
| 10 | 28844692 | A Broad-Spectrum Inhibitor of CRISPR-Cas9. | Cell | 2017 | https://conductscience.org/library/papers/28844692 | PubMed |
| 11 | 24086164 | Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids. | PLoS Genet | 2013 | https://conductscience.org/library/papers/24086164 | PubMed |
| 12 | 29396999 | Progress of CRISPR-Cas Based Genome Editing in Photosynthetic Microbes. | Biotechnol J | 2018 | https://conductscience.org/library/papers/29396999 | PubMed |
| 13 | 27836667 | Exploring the potential of genome editing CRISPR-Cas9 technology. | Gene | 2017 | https://conductscience.org/library/papers/27836667 | PubMed |
| 14 | 24445449 | Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. | Nat Commun | 2014 | https://conductscience.org/library/papers/24445449 | PubMed |
| 15 | 29062071 | Anti-CRISPR: discovery, mechanism and function. | Nat Rev Microbiol | 2018 | https://conductscience.org/library/papers/29062071 | PubMed |
| 16 | 24473129 | Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems. | mBio | 2014 | https://conductscience.org/library/papers/24473129 | PubMed |
| 17 | 28232956 | Scaffolding bacterial genomes and probing host-virus interactions in gut microbiome by proximity ligation (chromosome capture) assay. | Sci Adv | 2017 | https://conductscience.org/library/papers/28232956 | PubMed |
| 18 | 19713526 | Functional characterization of the antibiotic resistance reservoir in the human microflora. | Science | 2009 | https://conductscience.org/library/papers/19713526 | PubMed |
| 19 | 26060300 | Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26060300 | PubMed |
| 20 | 28469274 | CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum. | Nat Commun | 2017 | https://conductscience.org/library/papers/28469274 | PubMed |
Cited by79
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 99 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42678547 | CRISPR-cas systems in pharmacology: functional pharmacogenomics, drug screening, resistance, and therapeutic translation. | Funct Integr Genomics | 2026 | https://conductscience.org/library/papers/42678547 | PubMed |
| 42637903 | "Lariocidin and ribosome-targeting lasso peptides as emerging antimicrobial agents against multidrug-resistant bacteria". | J Antibiot (Tokyo) | 2026 | https://conductscience.org/library/papers/42637903 | PubMed |
| 42554845 | CRISPR/Cas system as a novel therapeutic strategy to combat multi-drug-resistant bacteria. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42554845 | PubMed |
| 42529233 | Identification, resistance mechanisms, and innovative therapeutic approaches against Acinetobacter baumannii-calcoaceticus complex. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42529233 | PubMed |
| 42497250 | Energy-assisted CRISPR cleavage and probiotic vesicle signaling platform: Microbiome reprogramming for homeostasis. | Sci Adv | 2026 | https://conductscience.org/library/papers/42497250 | PubMed |
| 42451761 | Next-Generation Strategies to Encounter Antimicrobial Resistance (AMR): From Lariocidin to Gene Editing and Nanotechnology-Based Approaches. | Molecules | 2026 | https://conductscience.org/library/papers/42451761 | PubMed |
| 42347171 | Bacteriophage-Based Therapeutics for Bacterial Sexually Transmitted Infections: From Biological Barriers to Translational Strategies. | Pathogens | 2026 | https://conductscience.org/library/papers/42347171 | PubMed |
| 42211656 | CRISPR-driven strategies to disrupt methicillin-resistant Staphylococcus aureus biofilms: a review. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42211656 | PubMed |
| 41994271 | Next-generation bacteriophage therapeutic systems: CRISPR-based engineering, near-infrared bioimaging, and precision strategies for treating multidrug-resistant and extensively drug-resistant bacterial infections. | Front Microbiol | 2026 | https://conductscience.org/library/papers/41994271 | PubMed |
| 41923586 | Emerging synthetic biology-assisted technologies for overcoming antibiotic resistance: CRISPR-Cas, bacteriophage, microbiome, and metabolic engineering-based solutions. | J Microbiol | 2026 | https://conductscience.org/library/papers/41923586 | PubMed |
| 41712626 | CRISPR-Cas is beneficial in plasmid competition, but limited by competitor toxin-antitoxin activity when horizontally transferred. | PLoS Biol | 2026 | https://conductscience.org/library/papers/41712626 | PubMed |
| 41600675 | Avian Pathogenic Escherichia coli: Advances in Pathogenesis, Diagnosis, and Control. | Vet Sci | 2025 | https://conductscience.org/library/papers/41600675 | PubMed |
| 41599772 | Bovine Mastitis Therapy at a Crossroads: Pharmacokinetic Barriers, Biofilms, Antimicrobial Resistance, and Emerging Solutions. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41599772 | PubMed |
| 41599202 | CRISPR-Cas-Mediated Reprogramming Strategies to Overcome Antimicrobial Resistance. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41599202 | PubMed |
| 41333289 | Genomics, population dynamics, immune evasion and resistance determinants foster the competence and global dissemination of Klebsiella pneumoniae. | PeerJ | 2025 | https://conductscience.org/library/papers/41333289 | PubMed |
| 41085803 | CRISPR-Cas systems in combating antimicrobial resistance: which system to choose? A systematic review. | World J Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/41085803 | PubMed |
| 41009471 | The Gut Microbiome and Colistin Resistance: A Hidden Driver of Antimicrobial Failure. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009471 | PubMed |
| 40521034 | Harnessing bacterial immunity: CRISPR-Cas system as a versatile tool in combating pathogens and revolutionizing medicine. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40521034 | PubMed |
| 40481260 | Antibiotic potentiators as a promising strategy for combating antibiotic resistance. | NPJ Antimicrob Resist | 2025 | https://conductscience.org/library/papers/40481260 | PubMed |
| 40447846 | Antibiotics re-booted-time to kick back against drug resistance. | NPJ Antimicrob Resist | 2025 | https://conductscience.org/library/papers/40447846 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29902258
GET https://conductscience.org/api/papers/v1/29902258/references?page=2